Abstract
Higher rates of neo-adjuvant chemotherapy use among high-risk patients with advanced stage epithelial ovarian carcinoma is associated with improved outcomes (1235)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
